Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?
Fang
L Christine
LC
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Merrick
Gregory S
GS
Wallner
Kent E
KE